Frontier Capital Management CO LLC Dexcom Inc Transaction History

Frontier Capital Management CO LLC

$10.2 Billion
Q1 2024

A detailed history of Frontier Capital Management CO LLC transactions in Dexcom Inc stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 774,985 shares of DXCM stock, worth $92 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

774,985

Previous 793,272 2.31%

Holding current value

$92 Million

Previous $98.4 Million 9.2%

% of portfolio

1.05%

Previous 1.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $2.09 Million - $2.56 Million	-18,287 Reduced 2.31%	774,985 $107 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $25.8 Million - $42.5 Million	342,075 Added 75.81%	793,272 $98.4 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $21.9 Million - $35.1 Million	-254,773 Reduced 36.09%	451,197 $42.1 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $2.66 Million - $3.1 Million	-23,682 Reduced 3.25%	705,970 $90.7 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $3.6 Million - $4.25 Million	34,592 Added 4.98%	729,652 $84.8 Million

Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $3.83 Million - $5.53 Million	45,110 Added 6.94%	695,060 $78.7 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $1.96 Million - $2.42 Million	-25,643 Reduced 3.8%	649,950 $52.3 Million
Q2 2022 Jul 20, 2022	BUY	$67.99 - $132.89 $33.2 Million - $64.9 Million	488,749 Added 261.58%	675,593 $50.4 Million
Q1 2022 Apr 14, 2022	SELL	$94.08 - $130.2 $2.57 Million - $3.56 Million	-27,338 Reduced 12.76%	186,844 $95.6 Million
Q4 2021 Jan 19, 2022	SELL	$129.87 - $162.82 $6.15 Million - $7.71 Million	-47,362 Reduced 18.11%	214,182 $115 Million
Q3 2021 Oct 19, 2021	BUY	$106.71 - $143.18 $7.1 Million - $9.52 Million	66,493 Added 34.09%	261,544 $143 Million
Q2 2021 Aug 09, 2021	BUY	$80.99 - $107.93 $2.32 Million - $3.1 Million	28,696 Added 17.25%	195,051 $83.3 Million
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $5.38 Million - $6.64 Million	-63,399 Reduced 27.59%	166,355 $59.8 Million
Q4 2020 Jan 19, 2021	BUY	$78.0 - $104.5 $906,360 - $1.21 Million	11,620 Added 5.33%	229,754 $84.9 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $7.14 Million - $8.45 Million	-74,769 Reduced 25.53%	218,134 $89.9 Million
Q2 2020 Jul 17, 2020	SELL	$62.68 - $105.34 $7.55 Million - $12.7 Million	-120,378 Reduced 29.13%	292,903 $119 Million
Q1 2020 Apr 16, 2020	SELL	$47.79 - $75.63 $4.02 Million - $6.37 Million	-84,181 Reduced 16.92%	413,281 $111 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $6.14 Million - $9.6 Million	167,648 Added 50.83%	497,462 $109 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $2.35 Million - $2.89 Million	-66,064 Reduced 16.69%	329,814 $49.2 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $2.26 Million - $3.16 Million	81,145 Added 25.78%	395,878 $59.3 Million
Q1 2019 May 07, 2019	SELL	$28.07 - $38.18 $1.44 Million - $1.95 Million	-51,176 Reduced 13.99%	314,733 $37.5 Million
Q4 2018 Jan 25, 2019	SELL	$26.99 - $37.37 $1.64 Million - $2.28 Million	-60,905 Reduced 14.27%	365,909 $43.8 Million
Q3 2018 Oct 30, 2018	SELL	$23.35 - $36.72 $5.51 Million - $8.66 Million	-235,762 Reduced 35.58%	426,814 $61.1 Million
Q2 2018 Aug 03, 2018	SELL	$17.54 - $25.22 $3.3 Million - $4.75 Million	-188,318 Reduced 22.13%	662,576 $62.9 Million
Q1 2018 Apr 30, 2018	BUY	$13.06 - $18.54 $2.13 Million - $3.02 Million	162,737 Added 23.65%	850,894 $63.1 Million
Q4 2017 Jan 18, 2018	SELL	$11.12 - $15.38 $1.78 Million - $2.47 Million	-160,513 Reduced 18.91%	688,157 $39.5 Million
Q3 2017 Oct 31, 2017	BUY	$11.36 - $18.98 $9.64 Million - $16.1 Million	848,670	848,670 $41.5 Million

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

352M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $45.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account

Frontier Capital Management CO LLC Dexcom Inc Transaction History